logo
v4.0
登录 注册
商品名
活性成分
中文名称
申请类型
申请号
剂型
申请机构
批准日期
Plozasiran
NDA
219947
Injection
Arrowhead Pharmaceuticals Inc
2025-11-18
Aprepitant
阿瑞匹坦
ANDA
216976
Injection, Emulsion
Mylan Pharmaceuticals Inc
2025-11-17
Tofacitinib Citrate
枸橼酸托法替布
ANDA
219442
Tablet, Extended Release;Oral
Biocon Pharma
2025-11-17
Loperamide Hydrochloride
盐酸洛哌丁胺
ANDA
220153
Tablet;Oral
Marksans Pharma
2025-11-17
Diphenhydramine Hydrochloride
盐酸苯海拉明
ANDA
205337
Injectable;Injection
Avet Lifesciences
2025-11-14
Rivaroxaban
利伐沙班
ANDA
208579
Tablet;Oral
Apotex
2025-11-14
Diazepam
地西泮
ANDA
217468
Gel;Rectal
Navinta Llc
2025-11-14
Fosfomycin Tromethamine
复美欣氨基丁三醇
ANDA
217608
For Solution;Oral
Aurobindo Pharma Ltd
2025-11-14
Diltiazem Hydrochloride
盐酸地尔硫䓬
ANDA
217633
Tablet;Oral
Alembic
2025-11-14
Lenalidomide
来那度胺
ANDA
218872
Capsule;Oral
Accord Hlthcare
2025-11-14
Voriconazole
伏立康唑
ANDA
220043
Powder;Intravenous
Hainan Poly Pharm
2025-11-14
Brivaracetam
布立西坦
ANDA
214921
Tablet;Oral
Msn
2025-11-13
Leuprolide Acetate
醋酸亮丙瑞林
ANDA
215826
Solution;Subcutaneous
Zydus Pharms
2025-11-13
Palbociclib
哌柏西利
ANDA
217365
Capsule
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2025-11-13
Iohexol
碘海醇
ANDA
217737
Solution;Injection, Oral, Rectal
Amneal
2025-11-13
Verapamil Hydrochloride
盐酸维拉帕米
ANDA
218218
Injectable;Injection
Aspiro
2025-11-13
Atorvastatin Calcium
阿托伐他汀钙
ANDA
220276
Tablet;Oral
Teva Pharms Inc
2025-11-13
Ziftomenib
齐托美尼布
NDA
220305
Capsule
Kura Oncology Inc
2025-11-13
Pertuzumab-dpzb
BLA
761450
Injectable;Intravenous
Shanghai Henlius Biotech
2025-11-13
Sitagliptin
西格列汀
ANDA
216057
Tablet
Laurus Labs Ltd
2025-11-12
%s %s
共 28316 条 上一页 1 2345 10 下一页 到第 查看50页数据